Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

28.78 +0.15 (+0.52%)
Official Closing Price Updated: 7:00 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Inside Cathie Wood’s Portfolio: 3 Stocks She Is Betting Millions On
Are you looking to invest in disrupting stocks like Cathie Woods? Here are three stocks Cathie Wood is betting millions on. 
Via InvestorPlace
3 Top Dividend Stocks to Buy for Long-Term Growth
These long-term dividend stocks to buy represent companies with high cash flow potential for dividend growth. 
Via InvestorPlace
Pfizer (PFE) Q3 2023 Earnings Call Transcript
PFE earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Dressed Up For Data: Halloween Dawns With Head Spinning Amounts Of Numbers, Stocks On Pace For Monthly Loss
(Tuesday market open) A scary October for stocks skids to the finish line today with major U.S. indexes on pace to post  their third straight monthly loss for the first time since early 2020 despite... 
Via Benzinga
Treasury Announcement More Important Than Fed's, Japan Abandons Yield Control, Tesla Under $200
To gain an edge, this is what you need to know today. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Pfizer's Coming for AbbVie's Market Share. Here's What It Means for Investors
AbbVie has a head start, but that might not be enough to save its top line. 
Via The Motley Fool
Today's Pharma Tales Of Loss And Success: Pfizer Swings To A Quarterly Loss And Mainz Biomed Reports Positive Interim Screening Campaign Results
As it struggles to navigate the rapid decline of its Covid-19 fame, Pfizer Inc (NYSE: PFE) reported a quarterly loss for the third quarter. 
Via Benzinga
Exposures COVID-19
US Stocks Fall; Pfizer Swings To Q3 Loss
U.S. stocks traded lower this morning, following the release of economic reports. Following the market opening Tuesday, the Dow traded down 0.25% to 32,845.12 while the NASDAQ fell 0.50% to 12,726.17.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Pfizer Skids As Covid Products Drive 41% Sales Decline, Losses
The company reported wider-than-expected losses and light third-quarter sales. 
Via Investor's Business Daily
Exposures COVID-19
Pfizer Q3 Earnings: Drugmaker Swings To Quarterly Loss On COVID-19 Write-Offs, Sales Fall 42%
Pfizer Inc (NYSE: PFE) has reported a Q3 adjusted EPS loss of $(0.17) versus a consensus loss of $(0.32), down from EPS inc 
Via Benzinga
Exposures COVID-19
Pfizer Earnings Preview
Via Benzinga
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
U.S. Stocks Poised To Extend Gains As Fed Meeting Gets Underway; Why This Analyst Expects 'Young Bull Market' To Remain Alive
US stocks are priming for a modestly higher open on Tuesday as traders look to another slew of earnings and the Fed decision. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Earnings Scheduled For October 31, 2023
Companies Reporting Before The Bell • BBVA (NYSE:BBVA) is likely to report earnings for its third quarter. • BP (NYSE:BP) is expected to report quarterly earnings at $1.37 per share on revenue of... 
Via Benzinga
3 No-Brainer Stocks to Buy With $50 Right Now
These stocks have declined in the double digits over the past few months. 
Via The Motley Fool
Investor Fear Eases Ahead Of Fed's Decision; Dow Notches Best Day Since June
The CNN Money Fear and Greed index showed easing in the overall fear level, with the index moving to the "Fear" zone on Monday. U.S. stocks closed sharply higher on Monday, with the Dow Jones recording... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Pfizer, AMD And 3 Stocks To Watch Heading Into Tuesday
With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Stocks Jump... Everything Else Dumps
Once again the fact that WW3 didn't actually break-out over the weekend sent VIX lower, smashing stocks higher and havens/hedges such as oil, crude, bonds, the dollar, and bitcoin all declined. 
Via Talk Markets
Topics Bonds Stocks
Exposures Debt Markets US Equities
7 Low-Risk Stock Picks to Double Your Money
As we get closer to the new year, investors may want to consider these top, low-risk stocks to double your money. 
Via InvestorPlace
Monday's Market Minute: Fed In Focus This Week, But Plenty Of Earnings & Data As Well
While the primary focus this week will be on the Federal Reserve’s policy announcement on Wednesday, it never hurts to take a market minute to look at a few of the other focal points for investors and... 
Via Benzinga
Topics Economy
Exposures Interest Rates
GSK's Competitive Edge, Surpasses Pfizer in Respiratory Syncytial Virus Vaccine Sales
GSK (NYSE: GSK) has reportedly taken an early lead in the race for respiratory syncytial virus (RSV) vaccine dominance, surpassing Pfizer Inc (NYSE: PFE), which previously dominated the COVID-19... 
Via Benzinga
Exposures COVID-19
The 7 Most Undervalued Long-Term Stocks to Buy: October 2023
Equities remain under pressure, but if you’re looking to be a contrarian investor, it’s a good time to look for undervalued long-term stocks. 
Via InvestorPlace
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
The U.S. 
Via Benzinga
Exposures Product Safety
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
The three companies are spending big on IBD therapies. 
Via The Motley Fool
Bears Roam Wall Street As Middle East Conflict, Earnings Outlook Raise Concerns Despite Strong Q3 US Economic Growth: This Week In Markets
It has been another week of volatility in the stock market, characterized by mounting fears of a wider Middle East conflict and a more cautious fourth-quarter earnings outlook announced by U.S.... 
Via Benzinga
CRSP Stock: FDA Considers Additional Review of CRISPR Therapeutics Gene Therapy
Although CRISPR Therapeutics may have a breakthrough drug on its hands, regulatory concerns hang over CRSP stock. 
Via InvestorPlace
Exposures Product Safety
FDA Gives Nod To Eli Lilly's First Treatment For Type Of Inflammatory Bowel Disease, To Compete With JNJ, Pfizer, AbbVie
The FDA approved Eli Lilly And Co's  
Via Benzinga
Exposures Product Safety
SNY Stock Sinks 15% as Sanofi Plans Consumer Unit Spinoff
The happy talk in Sanofi's press release didn't help with analysts, who have been disappointed in the company and SNY stock all year. 
Via InvestorPlace
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story. 
Via Investor's Business Daily
The 7 Most Undervalued Dividend Stocks to Buy: October 2023
These are the undervalued dividend stocks to buy as they represent blue-chip stocks with robust cash flows and steady growth visibility. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.